全文获取类型
收费全文 | 47621篇 |
免费 | 3483篇 |
国内免费 | 1618篇 |
专业分类
耳鼻咽喉 | 214篇 |
儿科学 | 1146篇 |
妇产科学 | 606篇 |
基础医学 | 7638篇 |
口腔科学 | 1132篇 |
临床医学 | 3385篇 |
内科学 | 7214篇 |
皮肤病学 | 887篇 |
神经病学 | 3743篇 |
特种医学 | 738篇 |
外国民族医学 | 11篇 |
外科学 | 3525篇 |
综合类 | 7053篇 |
现状与发展 | 4篇 |
预防医学 | 2116篇 |
眼科学 | 616篇 |
药学 | 7027篇 |
5篇 | |
中国医学 | 2237篇 |
肿瘤学 | 3425篇 |
出版年
2024年 | 101篇 |
2023年 | 847篇 |
2022年 | 2058篇 |
2021年 | 1967篇 |
2020年 | 1581篇 |
2019年 | 1650篇 |
2018年 | 1643篇 |
2017年 | 1576篇 |
2016年 | 1454篇 |
2015年 | 1552篇 |
2014年 | 2523篇 |
2013年 | 2826篇 |
2012年 | 2365篇 |
2011年 | 2815篇 |
2010年 | 2241篇 |
2009年 | 2301篇 |
2008年 | 2319篇 |
2007年 | 2157篇 |
2006年 | 1983篇 |
2005年 | 1901篇 |
2004年 | 1733篇 |
2003年 | 1501篇 |
2002年 | 1248篇 |
2001年 | 1003篇 |
2000年 | 973篇 |
1999年 | 822篇 |
1998年 | 721篇 |
1997年 | 722篇 |
1996年 | 668篇 |
1995年 | 651篇 |
1994年 | 528篇 |
1993年 | 394篇 |
1992年 | 301篇 |
1991年 | 312篇 |
1990年 | 235篇 |
1989年 | 184篇 |
1988年 | 193篇 |
1987年 | 153篇 |
1986年 | 155篇 |
1985年 | 311篇 |
1984年 | 315篇 |
1983年 | 240篇 |
1982年 | 274篇 |
1981年 | 215篇 |
1980年 | 198篇 |
1979年 | 181篇 |
1978年 | 135篇 |
1977年 | 94篇 |
1976年 | 103篇 |
1975年 | 91篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
利培酮治疗与细胞色素P4502D6/C188T酶基因多态性的关联分析 总被引:2,自引:0,他引:2
目的 研究利培酮临床效应的个体差异与其代谢酶细胞色素P4 5 0 2D6 (cytochromeP4 5 02D6 ,CYP2D6 )酶基因多态性的相关性。方法 对 88例符合CCMD 3精神分裂症诊断标准的患者和 96例健康对照者作病例 -对照分析。精神分裂症患者给予利培酮治疗 8周 ,用阳性和阴性症状量表 (posi tiveandnegativesymptomscale ,PANSS)评分评价利培酮疗效。采用聚合酶链反应扩增及限制性片段长度多态性 (PCR RFLP)技术对CYP2D6exonⅠ的C188T位点突变进行检测 ,分析利培酮临床效应与其主要代谢酶CYP2D6 /C188T酶基因多态性的相关性。结果 中国上海地区人群的CYP2D6 /C188T突变率(弱代谢型 )为 36 .3% ,病例组和正常对照组间基因型频率总体分布比较无显著差异 (χ2 =1.15 ,df=2 ,P >0 .0 5 ) ,两组间的等位基因频率之间比较也无显著性差异 (χ2 =0 .78,df=1,P >0 .0 5 )。进行性别及有否家族史分组后分析 ,亦无差异存在 ,且CYP2D6 /C188T突变与利培酮临床效应之间并无相关性 (χ2 =1.12 ,df=2 ;χ2 =0 .0 3,df=1,P >0 .0 5 )。结论 未发现中国人CYP2D6 /C188T多态性与利培酮临床效应的个体差异有相关性。 相似文献
42.
Interactions Between Cytomegalovirus, Human Herpesvirus-6, and the Recurrence of Hepatitis C After Liver Transplantation 总被引:1,自引:0,他引:1
Atul Humar Deepali Kumar Janet Raboud Angela M. Caliendo George Moussa Gary Levy Tony Mazzulli 《American journal of transplantation》2002,2(5):461-466
Recurrence of hepatitis C (HCV) following liver transplantation is common. Herpesvirus reactivation following transplant may have an immunomodulatory effect resulting in increased HCV replication. We studied whether cytomegalovirus (CMV) and human herpesvirus-6 (HHV-6) may be associated with HCV recurrence and viral load after transplant. We prospectively followed 66 HCV liver-transplant recipients with serial viral load testing for CMV and HHV-6. Infection and viral load were correlated with the development of biopsy-proven HCV recurrence and HCV viral loads. Histologic recurrence of HCV occurred in 41/66 (62.1%) patients. In the primary analysis, CMV infection and disease, and HHV-6 infection were not associated with HCV recurrence. Peak CMV and HHV-6 viral loads were not significantly different in patients with and without recurrence. No correlation was observed between HCV viral loads at 1 and 3 months post-transplant and peak HHV-6 or CMV viral loads. In a subgroup analysis, HHV-6 infection was associated with the development of more severe recurrence (hepatitis and/or fibrosis score > or = 2) (p = 0.01). Also, fibrosis scores at last follow up were higher in patients with CMV disease (1.67 vs. 0.56; p = 0.016) and in patients with HHV-6 infection (1.18 vs. 0.55; p = 0.031). In conclusion, HHV-6 and CMV infection and viral load were not associated with increased overall rates of HCV recurrence or HCV viral load after liver transplantation but may be associated with more severe forms of recurrence. 相似文献
43.
益肾化浊注射液对慢性肾功能衰竭大鼠残余肾中细胞因子含量的影响 总被引:2,自引:0,他引:2
通过观察益肾化浊注射液对5/6肾切除大鼠残余肾中细胞因子含量的影响,益肾化浊注射液延缓慢性肾功能衰竭(CRF)模型大鼠肾功能减退的作用机理。结果显示:益肾化浊注射液可以降低5/6肾切在鼠血清肌,尿素氮(P<0.01),下调肾组织中白细胞介素-1(IL-1)(P<0.05),白细胞介素-8(IL-8)(P<0.05)及肿瘤坏死因子(TNF)(P<0.05)的总体水平,说明益肾化浊注射液可以通过下调5/6肾切除大鼠残余肾中相关细胞因子含量,抑制促炎细胞因子对肾脏的损害,从而延缓CRF的进展。 相似文献
44.
骨感染病人TNF-α、IL-6和C反应蛋白的检测及临床意义 总被引:1,自引:0,他引:1
①目的 探讨骨感染病人肿瘤坏死因子α(TNF α)、白细胞介素 6 (IL 6 )和C反应蛋白 (CRP)水平的变化及意义。②方法 采用双抗体夹心ELISA法测定 30例骨感染病人及 2 5例正常人的血清TNF α、IL 6水平 ,采用散射比浊法测定CRP水平。③结果 骨感染病人血清中TNF α、IL 6及CRP含量均处于高水平状态 ,与健康人比较 ,差异有显著性 (t=2 .2 6~ 10 .6 7,P <0 .0 5、0 .0 1)。④结论 TNF α、IL 6及CRP是预测骨感染病人病情危重的重要指标之一 ,对临床有一定指导意义 相似文献
45.
46.
47.
Zhang Gui-mei Hao Tian-ling Yang Yu-zhen Feng Zuo-hua Jiang Zhi-yao Zhou Bin Zhang Hui 《华中科技大学学报(医学英德文版)》1992,12(3):150-153
Summary Effects of Chinese Medicinal Preparation “Re Du Qing” (RDQ) on the activation, proliferation and membrane fluidity of T lymphocytes
from human peripheral blood Were studied by means of3H-TdR incorporation and DPH fluorescence polarization. The results showed that “RDQ” can:1) significantly inhibit the activation
of T lymphocytes; 2) restrain the proliferation of activated T lymphoblasts in the presence of exogenous interleukin-2 (IL-2);
and 3) increase the membrane fluidity of T lymphocytes and antagonize the decreased fluidity of lymphocyte membrane mediated
by Con A or PHA. The functional abnormalities of T lymphocytes in some autoimmune diseases such as arthritis and the usefulness
of RDQ in the treatment of these diseases were also discussed. 相似文献
48.
Patrick Terheyden Jürgen C. Becker Christa Lurz George J. Kahaly Eva‐B. Brcker 《Journal der Deutschen Dermatologischen Gesellschaft》2003,1(1):30-35
Background: Scleromyxoedema is a rare disease of unknown aetiology that is characterized by deposition of mucin and sclerotic induration of the skin; it is associated with paraproteinaemia. Patients suffer from progressive disability due to immobilization and cosmetic disfigurement. Treatment of scleromyxoedema is a therapeutic challenge. The antimalarial hydroxychloroquine has a rapid and reliable effect in reticular erythematous mucinosis. Patients and methods: Four consecutive patients (two women, two men; median age: 50 years) with scleromyxoedema, three of them with IgG λ paraprotein, were treated with hydroxychloroquine. Treatment was initiated with 600 mg p. o. for 10 days, followed by 400 mg for at least 4 weeks, and 200 mg thereafter. Results: Complete remission of skin manifestations was achieved in one patient, whereas three patients achieved a partial remission of 61+, 5 and 25 months' duration. Notably, three patients felt increased mobility and reduced firmness of skin during the first week of treatment, which was reflected in a rapid reduction in dermal thickness. In one patient, dysphagia was reverted as evidenced by normalization of oesophageal clearance. Paraproteinaemia was not influenced at all. Side effects included one case of electroretinogram abnormalities after 19 months of therapy and one case of leucopenia after 3 months. Conclusion: Hydroxychloroquine is an effective form of therapy for scleromyxoedema, leading to rapid and prolonged alleviation of symptoms. 相似文献
49.
琼脂糖胶/聚苯乙烯磺酸微囊化胰B细胞株MIN6作为人工生物胰的实验研究 总被引:1,自引:0,他引:1
应用琼脂糖胶/聚苯乙烯磺酸微囊化胰B细胞林MIN6作为人工生物胰进行大鼠皮下异种移植。结果表明,在不应用任何免疫抑制剂的情况下,大鼠皮下异种移植一周后,重新取出的微囊仍保持光滑完整的球状,其内MIN6细胞仍清晰可见,囊周无明显纤维化及粘着。胰岛素释放试验结果显示,低糖浓度刺激时胰岛素的释放量为19.20±1.35μU·10microbead-1/h;高糖浓度刺激时胰岛素的释放量达到51.47±3.80μU·100microbeads-1/h,约为低糖浓度时的2.7倍,与低糖浓度时比较其差异有高度显著性(P<0.001)。提示琼脂糖胶/聚苯乙烯磺酸微囊化胰B细胞林MIN6作为人工生物胰,既能保护移植物膜B细胞株MIN6免受排斥反应,也能维护膝B细胞株MIN6对糖刺激的有效的胰岛素分泌反应性。 相似文献
50.